Key result
Hypoxia induces GPR35 expression in cardiac myocytes through HIF-1 activation, suggesting GPR35 could serve as an early marker of progressive cardiac failure.
Why the study?
Does hypoxia regulate GPR35 expression via HIF-1 in cardiac myocytes and mouse models of heart failure?
Does hypoxia regulate GPR35 expression via HIF-1 in cardiac myocytes and mouse models of heart failure?
GPR35 expression is regulated by hypoxia via HIF-1 and may serve as an early marker of progressive cardiac failure.
Answers are grounded in this paper and cite their sources.
Should not change clinical monitoring; leaves open GPR35 as a hypoxia marker in human heart failure.
AIMS: G protein-coupled receptor 35 (GPR35) has been characterized to be one of the genes that are up-regulated in human heart failure. Since mechanisms controlling GPR35 expression are not known, we investigated the regulation of GPR35 gene and protein expression in cardiac myocytes and in the mouse models of cardiac failure. METHODS AND RESULTS: In cardiac myocytes, GPR35 gene expression was found to be exceptionally sensitive to hypoxia and induced by hypoxia-inducible factor-1 (HIF-1) activation. HIF-1-dependent regulation was established by genetic (HIF-1/VP16, Inhibitory Per/Arnt/Sim domain protein) and chemical [desferrioxamine (DFO)] modulation of the HIF-1 pathway and further confirmed by mutation analysis of the GPR35 promoter and by demonstrating direct binding of endogenous HIF-1 to the gene promoter. Hypoxia increased the number and density of GPR35 receptors on the cardiomyocyte cell membranes. Chemical GPR35 agonist Zaprinast caused GPR35 activation and receptor internalization in cardiac myocytes. In addition, overexpressed GPR35 disrupted actin cytoskeleton arrangement and caused morphological changes in cultured cardiomyocytes. GPR35 gene and protein expressions were also induced in mouse models of cardiac failure; the acute phase of myocardial infarction and during the compensatory and decompensatory phase of pressure-load induced cardiac hypertrophy. CONCLUSIONS: Cardiac expression of GPR35 is regulated by hypoxia through activation of HIF-1. The expression of GPR35 in mouse models of cardiac infarction and pressure load suggests that GPR35 could be used as an early marker of progressive cardiac failure.
No takes yet. Share an insight, caveat, or question.
Ronkainen et al. (2013) studied Cardiac failure. Hypoxia was evaluated on GPR35 gene and protein expression. Hypoxia induces GPR35 expression in cardiac myocytes through HIF-1 activation, suggesting GPR35 could serve as an early marker of progressive cardiac failure.
Synapse has enriched 10 related papers. Consider them for comparative context: